GB9020959D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number: GB9020959D0
Authority: GB; United Kingdom
Prior art keywords: novel compounds; novel; compounds
Prior art date: 1990-09-26
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

GB909020959A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Beecham Group PLC

Original Assignee

Beecham Group PLC

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-09-26

Filing date

1990-09-26

Publication date

1990-11-07

1990-09-26 Application filed by Beecham Group PLC filed Critical Beecham Group PLC

1990-09-26 Priority to GB909020959A priority Critical patent/GB9020959D0/en

1990-11-07 Publication of GB9020959D0 publication Critical patent/GB9020959D0/en

1991-09-23 Priority to AU85413/91A priority patent/AU653364B2/en

1991-09-23 Priority to EP91917224A priority patent/EP0550570A1/en

1991-09-23 Priority to CA002092430A priority patent/CA2092430A1/en

1991-09-23 Priority to KR1019930700919A priority patent/KR930702351A/en

1991-09-23 Priority to PCT/GB1991/001633 priority patent/WO1992005175A1/en

1991-09-23 Priority to JP3515543A priority patent/JPH06501251A/en

1991-09-24 Priority to NZ239921A priority patent/NZ239921A/en

1991-09-24 Priority to IE335091A priority patent/IE913350A1/en

1991-09-24 Priority to MX9101237A priority patent/MX9101237A/en

1991-09-24 Priority to ZA917610A priority patent/ZA917610B/en

1991-09-25 Priority to PT99062A priority patent/PT99062A/en

Status Pending legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pulmonology (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Immunology (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

GB909020959A 1990-09-26 1990-09-26 Novel compounds Pending GB9020959D0 (en)

Priority Applications (12)

Application Number	Priority Date	Filing Date	Title
GB909020959A GB9020959D0 (en)	1990-09-26	1990-09-26	Novel compounds
JP3515543A JPH06501251A (en)	1990-09-26	1991-09-23	xanthine derivative
KR1019930700919A KR930702351A (en)	1990-09-26	1991-09-23	Xanthine derivatives
EP91917224A EP0550570A1 (en)	1990-09-26	1991-09-23	Xanthine derivatives
CA002092430A CA2092430A1 (en)	1990-09-26	1991-09-23	Xanthine derivatives
AU85413/91A AU653364B2 (en)	1990-09-26	1991-09-23	Xanthine derivatives
PCT/GB1991/001633 WO1992005175A1 (en)	1990-09-26	1991-09-23	Xanthine derivatives
NZ239921A NZ239921A (en)	1990-09-26	1991-09-24	Substituted xanthine derivatives; medicaments.
IE335091A IE913350A1 (en)	1990-09-26	1991-09-24	Novel compounds
MX9101237A MX9101237A (en)	1990-09-26	1991-09-24	SUBSTITUTED XANTHINES AND PREPARATION PROCEDURE
ZA917610A ZA917610B (en)	1990-09-26	1991-09-24	Xanthine derivatives
PT99062A PT99062A (en)	1990-09-26	1991-09-25	PROCESS FOR THE PREPARATION OF XANTINE DERIVATIVES

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB909020959A GB9020959D0 (en)	1990-09-26	1990-09-26	Novel compounds

Publications (1)

Publication Number	Publication Date
GB9020959D0 true GB9020959D0 (en)	1990-11-07

Family

ID=10682788

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GB909020959A Pending GB9020959D0 (en)	1990-09-26	1990-09-26	Novel compounds

Country Status (12)

Country	Link
EP (1)	EP0550570A1 (en)
JP (1)	JPH06501251A (en)
KR (1)	KR930702351A (en)
AU (1)	AU653364B2 (en)
CA (1)	CA2092430A1 (en)
GB (1)	GB9020959D0 (en)
IE (1)	IE913350A1 (en)
MX (1)	MX9101237A (en)
NZ (1)	NZ239921A (en)
PT (1)	PT99062A (en)
WO (1)	WO1992005175A1 (en)
ZA (1)	ZA917610B (en)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5409934A (en) *	1990-12-21	1995-04-25	Smith; David G.	Xanthine derivatives
GB9210839D0 (en) *	1992-05-21	1992-07-08	Smithkline Beecham Plc	Novel compounds
US5817662A (en) *	1992-11-09	1998-10-06	Cell Therapeutics, Inc.	Substituted amino alkyl compounds
US5646156A (en) *	1994-04-25	1997-07-08	Merck & Co., Inc.	Inhibition of eosinophil activation through A3 adenosine receptor antagonism
US6066641A (en) *	1994-12-13	2000-05-23	Euro-Celtique S.A.	Aryl thioxanthines
CA2218548A1 (en) *	1995-05-19	1996-11-21	Chiroscience Limited	Xanthines and their therapeutic use
MA24682A1 (en) *	1997-10-23	1999-07-01	Smithkline Beecham Corp	NEW POLYMORPHIC FORMS OF CIPAMFYLLINE, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM
WO2002002560A2 (en) *	2000-07-04	2002-01-10	Novo Nordisk A/S	Purine-2,6-diones which are inhibitors of the enzyme dipeptidyl peptidase iv (dpp-iv)
KR20030014394A (en) *	2000-07-04	2003-02-17	노보 노르디스크 에이/에스	Heterocyclic compounds, which are inhibitors of the enzyme dpp-iv
US6821978B2 (en)	2000-09-19	2004-11-23	Schering Corporation	Xanthine phosphodiesterase V inhibitors
AR036674A1 (en)	2001-08-28	2004-09-29	Schering Corp	INHIBITORS OF PHOSPHODIESTERASE V OF GUANINA OF POLICICLICOS, PHARMACEUTICAL COMPOSITION, AND THE USE OF SUCH COMPOUNDS FOR THE PREPARATION OF MEDICINES TO TREAT PHYSIOLOGICAL DISORDERS
MXPA04004370A (en)	2001-11-09	2004-08-11	Schering Corp	Polycyclic guanine derivative phosphodiesterase v inhibitors.
SI1509525T1 (en)	2002-05-31	2006-12-31	Schering Corp	Process for preparing xanthine phosphodiesterase v inhibitors and precursors thereof
JP4491344B2 (en)	2002-06-17	2010-06-30	グラクソグループリミテッド	Purine derivatives as liver X receptor agonists
US7407955B2 (en)	2002-08-21	2008-08-05	Boehringer Ingelheim Pharma Gmbh & Co., Kg	8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US7312223B2 (en)	2003-07-31	2007-12-25	Schering Corporation	Metabolite of xanthine Phosphodiesterase 5 inhibitor and derivatives thereof useful for treatment of erectile dysfunction
WO2005058898A2 (en) *	2003-12-16	2005-06-30	Ranbaxy Laboratories Limited	Purine compounds which can be used as phosphodiesterase (pde) type iv inhibitors
US7501426B2 (en)	2004-02-18	2009-03-10	Boehringer Ingelheim International Gmbh	8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004030502A1 (en)	2004-06-24	2006-01-12	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Novel imidazoles and triazoles, their preparation and use as medicines
DE102004037554A1 (en)	2004-08-03	2006-03-16	Sanofi-Aventis Deutschland Gmbh	Substituted 8-aminoalkylthio-xanthines, process for their preparation and their use as medicaments
DE102004039507A1 (en) *	2004-08-14	2006-03-02	Sanofi-Aventis Deutschland Gmbh	Substituted 8-aminoalkoxi-xanthines, process for their preparation and their use as medicaments
DE102004054054A1 (en)	2004-11-05	2006-05-11	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Process for preparing chiral 8- (3-amino-piperidin-1-yl) -xanthines
DE102005035891A1 (en)	2005-07-30	2007-02-08	Boehringer Ingelheim Pharma Gmbh & Co. Kg	8- (3-amino-piperidin-1-yl) -xanthines, their preparation and their use as pharmaceuticals
PE20110235A1 (en)	2006-05-04	2011-04-14	Boehringer Ingelheim Int	PHARMACEUTICAL COMBINATIONS INCLUDING LINAGLIPTIN AND METMORPHINE
SG174054A1 (en)	2006-05-04	2011-09-29	Boehringer Ingelheim Int	Polymorphs
EP1852108A1 (en)	2006-05-04	2007-11-07	Boehringer Ingelheim Pharma GmbH & Co.KG	DPP IV inhibitor formulations
PE20140960A1 (en)	2008-04-03	2014-08-15	Boehringer Ingelheim Int	FORMULATIONS INVOLVING A DPP4 INHIBITOR
UY32030A (en)	2008-08-06	2010-03-26	Boehringer Ingelheim Int	"TREATMENT FOR DIABETES IN INAPPROPRIATE PATIENTS FOR THERAPY WITH METFORMIN"
BRPI0916997A2 (en)	2008-08-06	2020-12-15	Boehringer Ingelheim International Gmbh	DPP-4 INHIBITOR AND ITS USE
RU2011113823A (en)	2008-09-10	2012-10-20	БЕРИНГЕР ИНГЕЛЬХАЙМ ИНТЕРНАЦИОНАЛЬ ГмбХ (DE)	COMBINED THERAPY FOR THE TREATMENT OF DIABETES AND RELATED CONDITIONS
US20200155558A1 (en)	2018-11-20	2020-05-21	Boehringer Ingelheim International Gmbh	Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
EP2382216A1 (en)	2008-12-23	2011-11-02	Boehringer Ingelheim International GmbH	Salt forms of organic compound
AR074990A1 (en)	2009-01-07	2011-03-02	Boehringer Ingelheim Int	TREATMENT OF DIABETES IN PATIENTS WITH AN INAPPROPRIATE GLUCEMIC CONTROL THROUGH METFORMIN THERAPY
EP3646859A1 (en)	2009-11-27	2020-05-06	Boehringer Ingelheim International GmbH	Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin
NZ602921A (en)	2010-05-05	2016-01-29	Boehringer Ingelheim Int	Combination therapy comprising the administration of a glp-1 receptor agonist and a ddp-4 inhibitor
KR20230051307A (en)	2010-06-24	2023-04-17	베링거 인겔하임 인터내셔날 게엠베하	Diabetes therapy
AR083878A1 (en)	2010-11-15	2013-03-27	Boehringer Ingelheim Int	VASOPROTECTORA AND CARDIOPROTECTORA ANTIDIABETIC THERAPY, LINAGLIPTINA, TREATMENT METHOD
AU2012285904C1 (en)	2011-07-15	2017-08-31	Boehringer Ingelheim International Gmbh	Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions
US9555001B2 (en)	2012-03-07	2017-01-31	Boehringer Ingelheim International Gmbh	Pharmaceutical composition and uses thereof
US20130303462A1 (en)	2012-05-14	2013-11-14	Boehringer Ingelheim International Gmbh	Use of a dpp-4 inhibitor in podocytes related disorders and/or nephrotic syndrome
EP4151218A1 (en)	2012-05-14	2023-03-22	Boehringer Ingelheim International GmbH	Linagliptin, a xanthine derivative as dpp-4 inhibitor, for use in the treatment of sirs and/or sepsis
WO2013174767A1 (en)	2012-05-24	2013-11-28	Boehringer Ingelheim International Gmbh	A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
EP3110449B1 (en)	2014-02-28	2023-06-28	Boehringer Ingelheim International GmbH	Medical use of a dpp-4 inhibitor
EP3468562A1 (en)	2016-06-10	2019-04-17	Boehringer Ingelheim International GmbH	Combinations of linagliptin and metformin

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AT392968B (en) *	1987-01-30	1991-07-25	Sandoz Ag	NEW XANTINE DERIVATIVES
GB8826595D0 (en) *	1988-11-14	1988-12-21	Beecham Wuelfing Gmbh & Co Kg	Active compounds
GB8906792D0 (en) *	1989-03-23	1989-05-10	Beecham Wuelfing Gmbh & Co Kg	Treatment and compounds
GB9020921D0 (en) *	1990-09-26	1990-11-07	Beecham Group Plc	Novel compounds
AU9024591A (en) *	1990-10-25	1992-05-26	G.D. Searle & Co.	Biphenylalkyl xanthine compounds for treatment of cardiovascular disorders

1990
- 1990-09-26 GB GB909020959A patent/GB9020959D0/en active Pending
1991
- 1991-09-23 EP EP91917224A patent/EP0550570A1/en not_active Withdrawn
- 1991-09-23 KR KR1019930700919A patent/KR930702351A/en not_active Withdrawn
- 1991-09-23 JP JP3515543A patent/JPH06501251A/en active Pending
- 1991-09-23 WO PCT/GB1991/001633 patent/WO1992005175A1/en not_active Ceased
- 1991-09-23 AU AU85413/91A patent/AU653364B2/en not_active Ceased
- 1991-09-23 CA CA002092430A patent/CA2092430A1/en not_active Abandoned
- 1991-09-24 NZ NZ239921A patent/NZ239921A/en unknown
- 1991-09-24 MX MX9101237A patent/MX9101237A/en not_active IP Right Cessation
- 1991-09-24 IE IE335091A patent/IE913350A1/en unknown
- 1991-09-24 ZA ZA917610A patent/ZA917610B/en unknown
- 1991-09-25 PT PT99062A patent/PT99062A/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
AU8541391A (en)	1992-04-15
EP0550570A1 (en)	1993-07-14
IE913350A1 (en)	1992-04-08
PT99062A (en)	1992-08-31
ZA917610B (en)	1992-09-30
AU653364B2 (en)	1994-09-29
MX9101237A (en)	1992-05-04
WO1992005175A1 (en)	1992-04-02
NZ239921A (en)	1993-12-23
CA2092430A1 (en)	1992-03-27
KR930702351A (en)	1993-09-08
JPH06501251A (en)	1994-02-10

Publication	Publication Date	Title
GB9007762D0 (en)	1990-06-06	Novel compounds
GB9009542D0 (en)	1990-06-20	Novel compounds
GB9020959D0 (en)	1990-11-07	Novel compounds
AP9100305A0 (en)	1991-07-31	Novel compounds
GB9000846D0 (en)	1990-03-14	Novel compounds
GB9011861D0 (en)	1990-07-18	Novel compounds
GB9008078D0 (en)	1990-06-06	Novel compounds
GB9005737D0 (en)	1990-05-09	Novel compounds
GB9008065D0 (en)	1990-06-06	Novel compounds
GB9010296D0 (en)	1990-06-27	Novel compounds
GB9006728D0 (en)	1990-05-23	Novel compounds
GB9011656D0 (en)	1990-07-11	Novel compounds
GB9012697D0 (en)	1990-08-01	Novel compounds
GB9010297D0 (en)	1990-06-27	Novel compounds
GB9004437D0 (en)	1990-04-25	Novel compounds
GB9005492D0 (en)	1990-05-09	Novel compounds
GB9005493D0 (en)	1990-05-09	Novel compounds
GB9005494D0 (en)	1990-05-09	Novel compounds
GB9007735D0 (en)	1990-06-06	Novel compounds
GB9013344D0 (en)	1990-08-08	Novel compounds
GB9007944D0 (en)	1990-06-06	Novel compounds
GB9013120D0 (en)	1990-08-01	Novel compounds
GB9008063D0 (en)	1990-06-06	Novel compounds
GB9012698D0 (en)	1990-08-01	Novel compounds
GB9003136D0 (en)	1990-04-11	Novel compounds